Van Epps elected Fellow of the American College of Emergency Physicians

News & Events

A view into what’s really happening during gene editing for Precision CRISPR
September 22, 2022

Somin Lee and her research group developed a way to reduce trial and error in gene editing by getting a look at the process in real time.

Read Story
Durable coating kills the COVID virus and other germs in minutes
August 30, 2022

Polyurethane locks in the antimicrobial power of tea tree and cinnamon oils. The new technology could start making public spaces safer within a year.

Read Story
Neuroregeneration and Cognition Challenge Seed Fund Awards
August 12, 2022

We are pleased to announce the funding selections for the MNI-BI 2022 Neuroregeneration and Cognition Challenge seed fund competition.

Read Story
Default Featured Image
2022 BI Innovator Awards
August 4, 2022

Congratulations to the 2022 BI Innovator Award Recipients. BI Innovator awards recognize members of the BI research community who are active participants in the research, innovation and translational ecosystem at BI and making a difference in our community.

Read Story
New members join BI’s External Advisory Board
August 1, 2022

BI welcomes Carl Gordon and Natasha Shervani of OrbiMed as new members of its External Advisory Board.

Read Story
Sharon Glotzer
Glotzer receives Vannevar Bush Faculty Fellowship
July 25, 2022

Sharon Glotzer has received the Vannevar Bush Faculty Fellowship from the U.S. Department of Defense, becoming one of nine distinguished faculty scientists and engineers to receive the award this year.

Read Story
Lola Eniola-Adefeso and international team receive $7.5M for cardiovascular disease research
July 15, 2022

Lola Eniola-Adefeso is part of an international research team that recently received $7.5 million from the Leducq Foundation for their AntheroGEN project.

Read Story
$2.38M to test nano-engineered brain cancer treatment in mice
June 22, 2022

Joerg Lahann and Colin Greineder are part of the research team that received funding from the NIH to study a new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.

Read Story
New delivery method allows slow-release of broader array of peptide drugs in the body
June 10, 2022

A new study from the Schwendeman lab describes one of the first entirely new drug delivery microencapsulation approaches in decades.

Read Story
Nanobiotics: Model predicts how nanoparticles interact with proteins
May 19, 2022

Developed in the VanEpps and Kotov labs, a new machine learning model that predicts interactions between nanoparticles and proteins.

Read Story
Kotov joins American Academy of Arts and Sciences
May 2, 2022

Nick Kotov was named to the American Academy of Arts and Sciences for his significant contributions in scholarly and professional fields.

Read Story
Recovery from muscle loss injuries hindered by immune cell conflicts
April 8, 2022

Collaborative research in the Aguilar lab showed how two of the body’s natural injury responders conflict following traumatic muscle injuries.

Read Story
Evan Keller
Keller Named Director of Research Cores
February 18, 2022

Congratulations to Even Keller on joining OVPR as the inaugural Director of Research Cores.

Read Story
Kotov Lab & Univ. of Bath Researchers Discover New Photonic Effect
January 13, 2022

The collaboration developed a new photonic effect which could speed up the development of new antibiotics and drugs through automation.

Read Story
BI Welcomes Innovation Fellows
January 11, 2022

The Biointerfaces Institute is pleased to welcome our Inaugural Innovation Fellows, Dr. Anastasia Visheratina and Dr. Dylan Neale.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us